ATRC AtriCure Inc
Price (delayed)
$38.39
Market cap
$1.88B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.95
Enterprise value
$1.83B
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure
Highlights
ATRC's revenue is up by 17% year-on-year and by 4% since the previous quarter
The company's gross profit rose by 16% YoY and by 3.8% QoQ
ATRC's net income is down by 47% YoY and by 15% QoQ
AtriCure's EPS has decreased by 44% YoY and by 14% from the previous quarter
Key stats
What are the main financial stats of ATRC
Market
Valuations
Earnings
Shares outstanding
48.88M
Market cap
$1.88B
Enterprise value
$1.83B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.06
Price to sales (P/S)
3.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
Revenue
$465.31M
Gross profit
$347.52M
Operating income
-$40.01M
Net income
-$44.7M
EBIT
-$37.27M
EBITDA
-$18.53M
Free cash flow
$770,000
Per share
Balance sheet
Liquidity
EPS
-$0.95
EPS diluted
-$0.95
Free cash flow per share
$0.02
Book value per share
$9.46
Revenue per share
$9.91
TBVPS
$6.77
Total assets
$609.33M
Total liabilities
$148.36M
Debt
$76.53M
Equity
$460.97M
Working capital
$194.4M
Debt to equity
0.17
Current ratio
3.65
Quick ratio
2.49
Net debt/EBITDA
2.49
Margins
Efficiency
Dividend
EBITDA margin
-4%
Gross margin
74.7%
Net margin
-9.6%
Operating margin
-8.6%
Return on assets
-7.4%
Return on equity
-9.7%
Return on invested capital
-17.6%
Return on capital employed
-7%
Return on sales
-8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATRC stock price
How has the AtriCure stock price performed over time
Intraday
-1.97%
1 week
-6.23%
1 month
-3.13%
1 year
16.23%
YTD
25.62%
QTD
25.62%
Financial performance
How have AtriCure's revenue and profit performed over time
Revenue
$465.31M
Gross profit
$347.52M
Operating income
-$40.01M
Net income
-$44.7M
Gross margin
74.7%
Net margin
-9.6%
The operating income has decreased by 50% YoY and by 17% from the previous quarter
ATRC's net income is down by 47% YoY and by 15% QoQ
The operating margin has declined by 28% year-on-year and by 13% since the previous quarter
The net margin has contracted by 26% YoY and by 10% from the previous quarter
Growth
What is AtriCure's growth rate over time
Valuation
What is AtriCure stock price valuation
P/E
N/A
P/B
4.06
P/S
3.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.93
AtriCure's EPS has decreased by 44% YoY and by 14% from the previous quarter
ATRC's price to book (P/B) is 40% higher than its last 4 quarters average of 2.9 but 19% lower than its 5-year quarterly average of 5.0
ATRC's P/S is 48% below its 5-year quarterly average of 7.4 but 29% above its last 4 quarters average of 3.0
ATRC's revenue is up by 17% year-on-year and by 4% since the previous quarter
Efficiency
How efficient is AtriCure business performance
The company's return on invested capital has shrunk by 76% YoY and by 25% QoQ
The ROE has contracted by 47% YoY and by 15% from the previous quarter
AtriCure's return on assets has decreased by 45% YoY and by 16% QoQ
AtriCure's ROS has decreased by 40% YoY and by 16% from the previous quarter
Dividends
What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATRC.
Financial health
How did AtriCure financials performed over time
The current ratio is up by 2.2% year-on-year
AtriCure's quick ratio has decreased by 2.4% YoY
The debt is 83% less than the equity
The debt to equity has grown by 6% year-on-year
The debt has grown by 2.7% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.